Paul R Fortin

Paul R Fortin, MPH, MD, FRCPC

Dr. Fortin is a certified rheumatologist and a clinical epidemiologist. His research interests are both clinical and methodological. Clinically, Dr. Fortin has been working on a better understanding of the bio-psycho-social impact of chronic rheumatic diseases such as systemic lupus erythematosus (SLE), antiphospholipid antibody syndrome (APS), systemic autoimmune rheumatic diseases (SARD), osteoarthritis and rheumatoid arthritis. He is particularly interested in developing better interventions for the treatment of SLE, APS and SARD.

His methodological interests cover the development and validation of health status measures and other clinical tools such as measures of disease activity or damage in SLE. He has worked on the concept of clinically relevant change in lupus disease activity and, in collaboration with Dr. Michael Abrahamowicz, has developed new methods to better link the measure of change with that of clinical relevance.

His other methodological interests include the development of risk profiles for arterial or venous thrombosis in APS, the testing of treatments of disease activity or cardiovascular disease in SLE and the validation of biological markers such as platelet-derived microparticules in SARDs.

Lupus. 2017 Jan 01;:961203317713146
Chan K, Clarke AE, Ramsey-Goldman R, Foulkes W, Tessier Cloutier B, Urowitz MB, Gladman D, Nived O, Romero-Diaz J, Petri M, Ginzler E, Fortin PR, Bae SC, Wallace DJ, Yelin EH, Bernatsky S
Rheumatology (Oxford). 2016 Dec;55(12):2148-2155
Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larché M, Abu-Hakima M, Rodriguez-Reyna TS, Cabral-Castaneda AR,...

Tenured Professor of Medicine, Université Laval, Quebec City, Quebec, Canada; and Clinical Scientist, Centre de recherche du CHU de Québec – Université Laval, Quebec City, Quebec, Canada (primary appointments)
Tier 1 Canada Research Chair in Systemic Autoimmune Rheumatic Diseases
Member, Systemic Lupus International Collaborating Clinics (SLICC)